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ABSTRACT 
 
Proteins are widely used in research and in the pharmaceutical industry but the production of 
recombinant protein can be tedious, costly and time-consuming due to unwanted aggregation. 
Strategies to circumvent aggregation, e.g. the use of solubility tags, must be evaluated 
experimentally and successful results are not always obtained. Therefore, there is a need to 
develop novel solubility tags for problematic proteins. In this thesis, we propose that spiders’ 
own solubility tag – the N-terminal domain (NT) of the spider silk proteins (spidroins) –– can 
be harnessed to produce very aggregation-prone proteins. 
NT is a pH-sensitive relay and its conformational switch from monomer to dimer determine 
the assembly state of the spider silk proteins. However, the molecular mechanisms of NT 
dimerization are unclear. In this thesis we determined which residues regulate the dimerization 
of NT from major ampullate spidroin and investigated whether this mechanism is conserved 
between distantly related NTs. Our results showed that NT dimerization requires an initial 
electrostatic interaction mediated by aspartate 40 with lysine 65, and that upon lowering the 
pH, subsequent protonation of glutamates 79, 84 and 119 result in conformational changes and 
stabilization. Moreover, we provided evidence that charge attraction and multistep protonation 
is conserved between widely different NTs but is mediated by different sets of residues. 
On the basis of these findings, we designed the soluble and thermally stable NT* by disrupting 
the charge attraction between aspartate 40 and lysine 65. NT* was more efficient to promote 
solubility of aggregation-prone proteins and peptides than commonly used solubility tags. We 
hypothesized further that NT* would be a suitable tag to control the solubility of amyloidogenic 
proteins and, thereby prevent precocious aggregation. Our results support that NT* prevents 
aggregation of amyloidogenic proteins, allowing e.g. structural studies and identification of 
new anti-amyloid strategies. 
This thesis presents an entirely novel approach to produce aggregation-prone recombinant 
proteins using the biotechnological tool NT* which was conceived on the basis of how spiders 
store their spidroins at high concentration without precocious aggregation. 
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1 INTRODUCTION 
 
Biotechnological research applications which are protein-based require that proteins are 
produced at a low cost and at a large scale. Successful protein production necessitates to find 
conditions that ensure a good expression level, an easy purification process and a prolonged 
shelf-life of the protein. At the end of this route, the proteins must be soluble, stable and 
correctly folded to perform their biological activities, while failure to find the right conditions 
would result in aggregated and inactive proteins that may be a potential liability for health if 
the protein is to be used for medical applications. Due to the diversity of proteins, there is no 
generic methodology to meet these production requirements, and each parameter has to be 
tailored according to the properties of the protein of interest. A common strategy to ensure a 
successful production is the use of solubility-enhancing tags in fusion with the proteins of 
interest. Fusion tags are soluble proteins with chaperone-like activities and/or thermostable 
characteristics helping the proteins of interest to fold properly. The efficacy of a solubility tag 
depends on the nature of the protein of interest and the solubility-enhancing effect must be 
determined empirically. Some proteins are still not readily expressed and purified despite the 
now available array of fusion tags, and therefore, there is a need to develop solubility tags with 
improved properties. 
In order to identify new tags, we turned to spiders as we were intrigued by the complex, but 
yet elegant machinery they utilize to control the solubility of their silk proteins during storage. 
Spider silk protein (spidroin) solubility is affected by pH and fiber formation is mediated by 
the monomer/homodimer interconversion of the spidroin N-terminal domain (NT). However, 
the molecular details of the mechanisms by which NT work are still elusive. In this thesis work, 
we aim to harness the NT function as a natural solubility tag to develop a biotechnological tool 
devoted to the production of biomedically relevant proteins that have proven to be difficult to 
produce recombinantly. We determined the molecular mechanisms involved in the 
dimerization of NT (Papers I and II). Based on these findings we designed the mutant domain 
NT* that successfully enhanced the production of aggregation-prone proteins with therapeutic 
potential (Paper III) and provided a tool to study amyloid proteins (Papers IV and V).   
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2 PROTEIN STRUCTURE AND FOLDING 
 
2.1 INTRODUCTION TO PROTEINS 
Almost all biological activities of cells, such as the transport of molecules, the catalysis of 
biochemical reactions or the maintenance of their structural integrity, are achieved by their 
proteins. 
Proteins consist of polymerized amino acids that have a common structure with an amino group 
and a carboxyl group attached to the a-carbon. They are joined into long polypeptide chains 
by the formation of amide bonds (peptide bonds) between the carboxyl group of one amino 
acid and the amino group of another. The resulting polypeptide and its order of amino acid 
residues is referred to as the primary structure. The amino acids are classified according to the 
physicochemical properties of their side chains (Table 1). In the polypeptide, the hydrophobic 
amino acid residues participate in Van der Waals interactions and the hydrophilic residues are 
involved in the formation of hydrogen bonds. Ionizable residues can engage in charge-charge 
interactions or salt bridges when the electrostatic interaction is coupled with hydrogen bonding. 
Acidic and basic residues have modulable charges that depend on their environment as their 
pKa:s might be altered in a hydrophobic environment or in charge clusters (1, 2). Histidine is 
the most versatile residue under mammalian physiological conditions since its pKa value is 
close to physiological pH. Although most interactions are non-covalent, cysteines (Cys) can 
engage in disulfide bridges, a covalent bond formed by the linkage of thiol (-SH) groups from 
two Cys residues into an S-S bond and concomitant release of two hydrogens. 
Hydrogen bonding between atoms of the backbone chain and preferred angles for the latter, 
leads to the formation of a specific structural arrangement called secondary structure. Two 
types of secondary structures have been described by Pauling & Corey (3). The a-helix has a 
cylindrical shape where the carbonyl of a given residue forms a hydrogen bond with the amide 
that is located 4 residues further in the polypeptide chain. As a result, a-helices are quite 
compact since the residues involved in this type of structure are close in space. In helices that 
are partly solvent exposed, the side chains of hydrophobic residues point towards the core of 
the protein whereas the side chains of hydrophilic residues are exposed to the solvent. The 
second type of secondary structure, b-sheets, are built from b-strands, which are stretches of 
residues with an extended backbone conformation and where the side chains of adjacent 
residues are pointing in opposite directions. Contiguous b-strands are stacked together by 
backbone hydrogen bonds and can involve residues relatively distant in the protein sequence. 
The b-sheets can be arranged either in an anti-parallel configuration or in a parallel manner.  
In the protein, the secondary structure elements and also parts of the polypeptide chain that lack 
defined structure interact with each other via hydrogen bonds, disulfide bridges, electrostatic, 
hydrophobic and Van der Waals interactions and make the structure collapse, i.e. to adopt a 
more compact fold where the hydrophobic patches are buried in the core of the protein. This 
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spatial organization of the polypeptide chain gives rise to the native conformation of the 
protein, which is also called the tertiary structure (4). While many proteins can have the same 
secondary structural elements, they fold into different tertiary structure. The configuration of 
the tertiary structure creates recognition sites that enable specific interactions with other 
molecules and allow the proteins to exert their biological functions. Some proteins require the 
formation of larger complexes composed of several folded polypeptides (subunits) for their 
activity. The manner in which the subunits are arranged is described as the quaternary structure 
of the protein. 
 
2.2 PROTEIN FOLDING 
Proteins need to adopt a thermodynamically stable three-dimensional conformation, known as 
the native state, in order to be functional. Most proteins exist in a stable, defined, structure, but 
intrinsically disordered proteins lack a defined native state, and are thought to fold upon 
encounter of interacting molecules. The folding of proteins, in vivo, is co-translational (5). In 
addition to native contacts – i.e. interactions existing in the final three-dimensional structure of 
a protein – short distance and transient non-native contacts are formed during folding of a 
protein (6-8). These interactions make the hydrophobic parts of the polypeptide cluster in one 
or several partially folded intermediate structures. However, it is still unclear how the correct 
folding of the native state is established.  
In the 1960’s, Anfinsen proposed that the amino acid sequence of a protein contains all the 
information necessary for folding (9). This postulate was made on the basis of the spontaneous 
folding of ribonuclease from a denatured state and without external help. Not only the intrinsic 
properties of the amino acid residues composing the protein but also their distribution in the 
sequence is important for folding, as different pattern of polar/non-polar residues can either 
lead to the formation of a-helices or b-sheets (10, 11). The influence of external factors (type 
of solvent, pH, etc.) during assembly cannot be neglected as they can alter the structure of the 
final product. For example, the transmembrane and very hydrophobic lung surfactant protein 
(SP) C folds into an alpha helix within the lipid bilayer but forms b-sheets in aqueous solutions 
(12, 13). 
Levinthal formulated a theory stating that proteins must take a predetermined pathway with 
different intermediates toward folding (14). He argued that given the high number of structures 
that a non-folded protein could adopt, trying out all conformations randomly would take an 
infinite amount of time. This theory is supported by studies of the folding process of short 
proteins (<100 residues) as they, indeed, fold in a fraction of a second in vitro (6). Moreover, 
the folding of small proteins is often described as a two-state transition as only one energy 
barrier has to be overcome (15). Transient states in a two-state folding model of small proteins 
are not affected by mutations which also suggest a preferential folding pathway (16).   
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Table 1: Summary of the 20 amino acids of the standard genetic code. 
Type Amino acid 3-letter code 1-letter code Chemical structure 
Aliphatic 
Alanine Ala A 
 
Glycine Gly G 
 
Leucine Leu L 
 
Isoleucine Ile I 
 
 
Valine Val V 
 
Aromatic 
Phenylalanine Phe F 
 
Tryptophan Tr W 
 
Tyrosine Tyr Y 
 
Cyclic Proline Pro P 
 
Basic 
Arginine Arg R 
 
Histidine His H 
 
Lysine Lys K 
 
Acidic 
Aspartic acid Asp D 
 
Glutamic acid Glu E 
 
Amine 
Asparagine Asn N 
 
Glutamine Gln Q 
 
Hydroxyl-containing 
Serine Ser S 
 
Threonine Thr T 
 
Sulfur-containing 
Cysteine Cys C 
 
Methionine Met M 
 
COOH
NH2
COOH
NH2
COOH
NH2
COOH
NH2
COOH
NH2
COOH
NH2
COOH
NH2HN
COOH
NH2HO
NH
COOH
COOH
NH2
H2N NH
NH
COOH
NH2N
N
H
COOH
NH2
H2N
COOH
NH2
HO
O
NH2
COOH
HO
O
COOH
NH2O
H2N
NH
COOH
O
H2N
NH2
COOHHO
NH2
COOH
NH2
COOH
HS
COOH
NH2
S
 5 
Another theory called the “new view” hypothesized that proteins populate various starting 
conformations. Therefore, proteins can take several routes and adopt diverse intermediate 
conformations before reaching their final native state (6, 17-20). While the proteins gain in 
stability as folding proceeds, the number of different low-energy intermediates to choose from 
becomes increasingly limited. As a result, the free-energy landscape, where the unfolded 
proteins navigate, is represented with a funnel shape as the energy converges to the low-energy 
native state (Figure 1). The walls of the hypothetical funnel are rugged because kinetic barriers 
have to be overcome (21, 22). Zwanzig and colleagues addressed Levinthal’s paradox by 
speculating that energy guides the folding process (23). Even if the search for conformations is 
random, the proteins do not have to explore all conformations as long as only the conformations 
decreasing the energy are chosen down the folding routes.  With this energy bias the routes to 
the native state take significantly less time than initially anticipated by Levinthal. Longer 
proteins tend to have more folding routes than short proteins and  mutations can direct proteins 
towards preferential folding routes (16). 
Despite great progress in the understanding of protein foldingit is not generally possible to 
predict protein structure from protein sequence only by computational methods and this 
remains a big challenge for protein scientists. Molecular dynamics simulations are currently 
limited to folding of small proteins with simple folds but they cannot accurately predict stability 
or thermodynamic properties of the studied proteins (6, 7). 
 
2.3 PROTEIN AGGREGATION 
The distinction between protein aggregation and protein folding can be tenuous as both 
pathways compete with each other and transient aggregates can be mistaken for folding 
intermediates (Figure 1) (24, 25).  Aggregation prone sequences and/or large hydrophobic 
patches may be solvent exposed in folding intermediates which is energetically unfavorable. 
Therefore, their exposure could favor the formation of non-native intermolecular interactions 
leading to protein aggregation (26-29).  
No general pathway for aggregations has been defined since aggregation depends on a wide 
range of conditions (30). The tendency to aggregate can be inherent to the protein if it has a 
sequence containing a high number of hydrophobic residues, forming aggregation prone 
regions (31). While aggregation can be driven by weak interactions only (32), proteins 
containing cysteines (Cys) can form covalently linked aggregates via formation of disulfide 
bridges (33). Furthermore, aggregation can be induced by mutations that insert hydrophobic 
residues within the sequence (34, 35). 
Modifying the environment of the protein also affects protein folding. Molecular crowding can 
favor aggregation under quiescent conditions since high protein concentration increases the 
number of contacts between molecules (36-38). The hydrophobic residues are not the only ones 
playing a role in protein aggregation. Indeed, basic and acidic residues are sensitive to changes 
of pH or screening effects exerted by salts, and hence both pH and ionic strength can affect 
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aggregation (39-43). Elevated temperature can transiently result in exposure of hydrophobic 
patches, by promoting partial unfolding and can increase the number of collisions between 
molecules (44, 45). Aggregation controlled by environmental changes is generally reversible 
(43, 46, 47) but sometimes the process can be irreversible, especially when it causes 
conformational changes of the proteins (43, 48). 
 
 
Figure 1: Schematic representation of the free energy landscape of protein folding and misfolding. 
Reproduced from Muntau et al. 2014 (49). 
 
Irreversibly misfolded proteins represent a danger to the cells since this results in inactive 
proteins. They can also induce the aggregation of other proteins and mislfoded proteins as such 
can be cytotoxic. The cells have developed a quality control system to prevent unwanted 
aggregation. Protein chaperones are recruited to assist folding and protect exposed hydrophobic 
patches (50). When the misfolded proteins cannot be rescued, they are addressed to the 
ubiquitin proteasome system or the autophagy system for degradation (51, 52). However, these 
mechanisms of control can deteriorate and the accumulation of amorphous aggregates can 
provoke diseases such as cataract (53) or inclusion body myotisis (54). A specific type of 
particularly stable aggregates called amyloid, in which the proteins adopt a b-sheet 
conformation and assemble into fibrils, has been linked to several diseases (Figure 1) (55-58). 
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2.4 AMYLOID PROTEINS 
Amyloid fibrils are proteinaceous assemblies defined by their tinctorial and ultrastructural 
properties and that are found in tissue deposits as well as in yeast and bacteria (59-62). Amyloid 
is associated with a set of diverse diseases, including transthyretin related amyloidosis, 
Alzheimer’s disease and Parkinson disease. No curative treatments have been found for these 
diseases, and the current treatments can only delay the progression of the diseases (63-65). 
Today, 36 diseases are known to be associated with amyloid fibrils (55-58). Amyloid diseases 
result from protein misfolding where proteins form insoluble fibrils composed of cross-β 
structures (55-57, 66, 67). The lack of available treatments is probably to a large extent the 
result of the poor understanding of the molecular mechanisms behind the cytotoxicity observed 
in association to amyloid fibril formation (68, 69). It has been suggested that fragmented fibrils 
jeopardize the integrity of lipid membrane bilayers and can disrupt cells (70, 71). However, 
there is no direct correlation between the number of fibrils and the appearance of symptoms. 
The surface of the fibrils catalyzes secondary nucleation events that are responsible for the 
formation of oligomers (72, 73), which are suspected to be the main toxic species (74-81).  
 
2.4.1 The amyloid-b peptide 
Alzheimer’s disease is reported to affect about 50 million people worldwide and age is the 
highest risk factor. Since the average population worldwide is getting older, about 130 million 
people are estimated to be affected by the disease in 2050 (82). The disease represents 75% of 
all dementia cases (83, 84). This neurodegenerative disease is characterized by the 
accumulation of different species of insoluble amyloid β (Aβ) proteins forming plaques in the 
brain (85, 86). This eventually results in memory loss and personality changes. In the quest for 
a better understanding of the disease on the molecular level, most attention has been focused 
on the 40-residue long Aβ1-40 and in particular the 42-residue long Aβ1-42, as it is the most 
abundant species in the plaques (87, 88), and also the most toxic Aβ species (89, 90). 
Ab1-42 has an identical sequence to Ab1-40 except for an extra C-terminal isoleucine (Ile) and 
alanine (Ala) dipetide motif. They have a rather hydrophilic N-terminal part (residue 1-16) 
while the C-terminal part (residue 17-42) is mainly hydrophobic. Circular dichroism (CD) and 
nuclear magnetic resonance (NMR) spectroscopy revealed that monomeric Ab1-40 and Ab1-
42 are unstructured in solution  (91-94). Determination of the structures of Ab1-40 and Ab1-
42 fibrils gave different results not only between the two petides but also between fibrils formed 
under different conditions and from different sources (95-99). Ab1-40 can adopt a b-turn-b 
conformation with two extended anti-parallel b-strands (100). Two independent structural 
studies revealed that Aβ1-42 fibrils are composed of two molecules per layer and in each 
subfibril Aβ forms a cross-β structure shaped like a double horseshoe (101, 102). In the 
subfibril, the N-terminal part of Aβ is partially ordered and dynamic with a single β-strand and 
an unstructured part. The C-terminal part is more rigid as it contains 4 β-strands and two are 
interacting with each other by hydrophobic interactions. A salt bridge between the side chain 
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of lysine (Lys) 28 and the carboxylate of Ala 42 was also identified (98, 101, 102). This salt 
bridge is absent in the shorter Aβ1-40 where Lys 28 interacts with aspartate (Asp) 23 instead 
(96, 100). Interestingly, two studies identified a highly similar structure despite the differences 
in the production of the peptide (Wälti et al. used recombinant expression (102) while Colvin 
et al. produced the peptide by organic synthesis (101)) and in the conditions used to obtain the 
fibrils. Colvin and colleagues proposed that this indicates that they found the most 
thermodynamically stable structure of Aβ1-42 fibrils (101). 
Studies revealed that Ab1-42 has a higher rate of fibrillization than Ab1-40 (103, 104) and no 
hetero fibrils were observed when both variants were co-incubated (105). The extra 
hydrophobic residues in Ab1-42 compared to Ab1-40  create a second exposed hydrophobic 
patch that may favor secondary nucleation and explain the higher rate of fibrillization of Aβ1-
42 compared to Aβ1-40. The incompatibility of the peptides in the fibrils is supported by the 
structural differences between Ab1-40 and Ab1-42. 
 
2.4.2 The amyloid-forming designed polypeptide b17 
Despite sequence and structural differences, all proteins involved in the diverse amyloid 
pathologies form fibrils (55). To better understand the molecular mechanisms behind 
amyloidogenesis, the amyloid-like polypeptide β17 was designed (11). This de novo protein 
alternates 6 β-strands, in which the residues are organized in a polar/non-polar pattern, with 5 
turns. The protein enables studies of amyloid formation as such, without interference from lost 
biological functions. In vitro studies showed that β17 is able to form amyloid fibrils (11, 106). 
When produced in the cytosol in eukaryotic cells, β17 fibrils promote the aggregation of mainly 
proteins with disordered regions, many of which are important for protein-protein interactions 
in signaling pathways, and newly synthesized proteins that still have not adopted their native 
states (106). The fibrils are then supposed to be toxic for the cells by sequestering important 
proteins. However, in the nucleus the toxicity is reduced and only cytosolic aggregates are 
shown to interfere with the nucleo-cytoplasmic transport (107). In the endoplasmic reticulum, 
largely unknown mechanisms, which might involve ER specific molecular chaperones, prevent 
β17 from fibrillating (108, 109). β17 is difficult to produce and study because of its tendency 
to aggregate. In E. coli, β17 aggregates into inclusion bodies and its purification requires the 
use of denaturing agents (11, 106). The instability of the purified protein, which aggregates 
rapidly, limits experimental studies of amyloid formation in vitro (108). 
 
2.5 SPIDER SILK PROTEINS 
Spider silk is one of the most remarkable polymers in nature with mechanical properties 
surpassing those of Kevlar and steel as this polymer is both extendable and strong (110, 111). 
Spider silk is also biodegradable and well tolerated when implanted in vivo (112, 113). These 
properties make spider silk a suitable candidate for various biomedical applications such as cell 
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culture matrices for stem cells (114, 115). The seven silk types that orb-weaving spiders use to 
satisfy diverse needs are described in Figure 2. The interest in producing artificial spider silk 
fibers is growing but the production is limited by the poor understanding of the molecular 
mechanisms driving fiber assembly and the limited information regarding the composition of 
the gland where spider silk is produced and stored.  
 
 
Figure 2: Illustration of female orb-weaving spider’s different silk glands and the function of their 
respective silk fibers. Adapted with permission from Rising & Johansson: Nature Springer, Nature 
Chemical Biology, (116), © 2015. 
 
Spider silk is the result of the polymerization of large proteins with variable length called 
spidroins. In order to respond quickly to the need of the spider, spidroins are synthesized 
beforehand and stored in abdominal glands which are silk specific (Figure 2). For the major 
ampullate spidroin (MaSp), a predicted signal peptide directs the protein to the secretory 
pathway in the tail of the gland (Figure 3 ) (117, 118). The spidroins are then stored as a liquid 
dope in the sac of the gland at neutral pH (119, 120), and at concentrations ranging from 30 to 
50 % w/v (121, 122). However, it is still unclear how the proteins are arranged in the dope to 
prevent precocious aggregation. It has been suggested that spidroins adopt a micellar structure 
in the dope (123-125) and/or are arranged in liquid crystalline networks (126).  
The silk fiber assembly occurs in the spinning duct where several factors such as pH, salt 
concentration and sheer forces are suspected to be fundamental in promoting assembly into 
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fibers (120, 127, 128). The pH is decreasing gradually along the duct, going from 7.2 at the 
proximal part to 5.7 midway, and reaching an unknown value, probably around pH 5, at the 
distal part of the duct (128-130). During the transit of spidroins in the duct, water is removed 
and exchange of ions occurs. All along the duct length, sodium concentration decreases 
whereas potassium and phosphate concentrations increase when compared to their 
concentrations in the proximal part of the duct (126).  
 
2.5.1 Spidroin structure  
All spidroins share a common architecture with a large repetitive central region flanked by 
short terminal domains (Figure 3) (131, 132). The central region of the spidroin is responsible 
for the mechanical properties of the silk fiber. The amino acid sequence of the central region is 
silk specific and gives each silk its unique mechanical properties (133). The C-terminal domain 
(CT) of the spidroin is relatively well conserved across silk types and spider species (134, 135). 
CT is an about 110 residue long and a-helical domain (128, 136-138) that form a constitutive 
parallel homodimer maintained mainly by hydrophobic and electrostatic interactions (136, 138, 
139). In vitro, upon lowering the pH, the a-helical CT unfolds and adopts a b-sheet 
conformation leading to the formation of amyloid-like fibrils (128, 140). Therefore, it is 
hypothesized that CT act as an amyloid seed nucleating the fibril formation of the spidroins 
and triggering the conformational change of the repetitive parts into b-sheets. Gao et al. 
proposed that the linker region, between the central repetitive region and CT, acts as nucleation 
site (136). 
 
2.5.2 The N-terminal domain (NT)  
2.5.2.1 Function  
NT is the most conserved region of the spidroin (117, 118, 131, 134), and this suggests a 
conserved function across silk types and species. A study on a miniature spidroin established 
that NT controls spidroin solubility in a pH dependent manner by preventing precocious 
aggregation at neutral pH (as like during storage in the gland) and by speeding up the fiber 
assembly at lower pH (corresponding to values observed in the duct) (141). 
The underlying molecular mechanisms of the NT function were early on investigated by 
dynamic light scattering and X-ray crystallography, and a study suggested that NT is a 
homodimer at pH 7, and forms large complexes at pH 6 (141). However, further experiments 
using electrospray ionization mass spectroscopy, size exclusion chromatography, dynamic 
light scattering and analytical ultracentrifugation could not confirm the formation of large 
complexes (142-144) and it was later shown that NT is mainly monomeric at neutral pH and 
forms a dimer at lower pH (143-147). 
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Figure 3: Illustration of the major ampullate gland describing the route of the spidroins. The spidroins 
are synthetized in the tail of the gland and stored in the sac conceivably in a micellar configuration at 
neutral pH. Assembly into fibers occurs during passage through the narrowing duct and is accompanied 
with a gradual decrease in pH. Reproduced from Paper III. 
 
NT is highly soluble at high pH and can be concentrated to more than 200 mg/mL without 
aggregation (148) despite that two thirds of the NT sequence are predicted to have high 
amyloidogenic propensity (149). The association/dissociation rates of NT are independent of 
its concentration (145, 149). This means that in the context of the crowded dope during the 
storage, only ionic strength (see below) and high pH affects the solubility of NT, i.e. by keeping 
the domain monomeric. A decreased pH leads to dimerization and global stabilization of the 
dimer. The dimerization might reduce the spidroin solubility during transit in the spinning duct 
(142, 144, 148, 150). Interestingly, NT monomers associate at a rate close to the speed limit of 
diffusion and such a feature most likely enables spidroins to rapidly assemble into fibers (145). 
However, most experiments were carried out on isolated NT, ie without the repetitive regions, 
and the presence of the latter might affect the assembly process. Furthermore, experiements 
have usually been performed with NT concentrations that are lower than those in the gland.  
2.5.2.2 Structure and molecular dynamics  
Structural studies of MaSp NT show that the domain is organized as a five-helix bundle (117, 
141, 143, 148, 151), and has no non-spidroin structural homologue to date (134). Structural 
differences are observed between the monomeric and dimeric conformation of NT. The 
arrangement of the helices in the monomer is dynamically flexible and incompatible with dimer 
formation (143, 147, 151). The homodimerization requires a rearrangement of the helices of 
the monomer subunits into a more compact conformation (147, 151). Moreover, the subunits 
in the dimer are asymmetric (151-153). The replacement of methionines (Met) in the core of 
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NT by leucines (Leu) results in the stabilization of monomeric NT and impairs dimerization, 
indicating that the plasticity of NT is driven by its methionines (147). Interestingly, a 
tryptophan (Trp) at position 10 is buried between helix 1 and 3 in the monomer and becomes 
surface exposed upon assembly (141, 142, 151). Trp 10 is a convenient probe to monitor the 
conformational switch of NT by fluorescence spectroscopy as the fluorescence of Trp is 
quenched and shifts towards a longer wavelength upon exposure to a polar solvent (141, 142, 
145-147). 
The pH responsiveness of NT is attributable to the dipolar distribution of its exposed acidic and 
basic residues. The N-terminal pole presents a cluster of positively charged amino acids while 
negatively charged amino acids congregate at the opposite C-terminal pole (141, 143). As a 
result, NT forms an antiparallel homodimer and the interactions between two subunits are 
mainly mediated by electrostatic interactions. The dissociation constant of the dimer is in the 
nanomolar range and reflects that the subunits are tightly bound in the dimer (145, 147). These 
interactions can be perturbed by the ionic strength since high salt concentrations (> 200 mM) 
delays dimerization by stabilizing monomer conformation (141-145, 147). The association rate 
of the monomer subunits is not affected by ionic strength but the dissociation rate increases at 
high salt concentration (145, 147). 
NT association has been proposed to follow a selected-fit model (146). In contrast to the 
induced-fit model, which postulate that the binding event of a ligand to a protein induces 
conformational changes, the selected-fit model suggests that since proteins are dynamic, they 
populate a range of conformations and ligands associate with their complementary 
conformations (154). It cannot be excluded that both models are involved as some studies 
highlight a general mechanism of protein association driven by selection-fit followed by fine-
tuning of the conformation after binding of the ligand (155, 156). 
 
3 RECOMBINANT PRODUCTION AND PURIFICATION OF 
PROTEINS  
 
Several organisms, both prokaryotic and eukaryotic, are today used for heterologous 
production of recombinant proteins and the choice of host depends on the properties of the 
protein and its intended use (Table 2). Eukaryotic cells, such as mammalian cells, are able to 
manufacture proteins with complex structures through chaperone activity and post-
translational modifications but they are costly to handle and the yield of production is typically 
low (157). Yeast species are noteworthy alternatives due to the comparatively simple culture 
conditions and their ability to perform some of the post-translational modifications seen in 
mammalian cells, including glycosylation (158, 159). Cell-free systems do not involve living 
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Table 2: Overview of the expression systems commonly employed for the production of proteins (160, 161)  
Expression system Common host Advantages Limitations 
Bacteria Escherichia coli 
Simple genetic manipulation  
Simple culture conditions  
High yields  
Cost-effective 
No post-translational modifications 
Inclusion body formation 
Endotoxin contamination 
Unfavorable conditions for disulfide bond formation 
Yeast 
Pichia pastoris 
Saccharomyces cerevisiae 
Simple genetic manipulation 
Post translational modifications 
Efficient secretion system  
High yields 
Cost-effective 
Growth conditions require optimization 
Limited pattern of post translational modifications 
Insect cells 
Spodoptera frugiperda  
Drosophila melanogaster 
Tolerate large proteins 
Complex post-translational modifications 
Medium yields 
Tedious culture conditions 
Expensive 
Time consuming 
Mammalian cells 
Chinese hamster ovary 
Human embryonic kidney 
Complex eukaryotic proteins 
Complex post-translational modifications 
Efficient folding machinery 
Tedious culture conditions 
Low yields  
Time consuming 
Expensive 
Increased biosafety level 
Cell-free Cell lysates 
Flexibility of expression conditions 
Incorporation of non-natural amino acids 
Production of toxic proteins 
Background synthesis from extract use up reagents 
Low yields 
Expensive 
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organisms and therefore present an advantage especially for membrane proteins and toxic 
proteins but they still need to be improved due to the low efficiency compared to the in vivo 
systems (160, 162). Escherichia coli is the most commonly used prokaryotic expression system 
for recombinant protein production. The bacteria are easy to culture since they divide every 20 
min (163), and they have a high expression yield with 1-20% of the total bacterial proteins 
corresponding to the recombinant proteins (164).  
 
3.1 COMMON ISSUES WITH THE PRODUCTION OF RECOMBINANT 
PROTEINS 
Despite the simplicity of using E. coli expression system, only 10 to 20% of all soluble 
heterologous proteins produced to date are expressed in and purified from E. coli (165, 166). 
Issues with expression and purifications of recombinant proteins are likely often unpublished, 
which makes it difficult to collect accurate data on this topic. 
Eukaryotes and prokaryotes have different protein production machineries and heterologous 
production of eukaryotic proteins can be overwhelming for the E. coli machinery, often due to 
the need for chaperone activity or post-translational modifications for the proper folding of the 
proteins. Consequently, proteins can misfold and/or aggregate into inclusion bodies. Inclusion 
bodies were initially thought to contain amorphous proteins, but structural studies show that 
the protein structure is often dominated by a b-sheet conformation (167-169). Mitraki & King 
proposed that formation of inclusion bodies is the consequence of the aggregation of folding 
intermediates which implies that the constituent proteins might retain structural characteristics 
resembling the native state (170). 
The disaggregation of inclusion bodies is a potential purification method since they are usually 
relatively pure (171). This type of aggregation is, however, not reversible by simple dilution 
and solubilization of inclusion bodies necessitates use of denaturing agents, such as urea or 
detergents (172-174). In many cases, the proteins can be refolded by lowering the concentration 
of the denaturing agents in a stepwise manner before or during purification. This process is 
labor-intensive, relatively expensive, and results in low protein yields and sometimes in 
inactive proteins when compared to purification under native conditions. Preventing the 
formation of inclusion bodies by decreasing the amount of proteins expressed is a good 
approach to produce soluble proteins, albeit the final yield will be considerably lower. This can 
be achieved by shortening the expression time, by reducing the amount of expression inducer 
or by lowering the temperature of expression since it slows down transcription and translation 
rates and gives more time for the protein to fold correctly (175-177). Another alternative to 
reduce protein aggregation is to co-express the target proteins with chaperones (178), or to use 
fusion tags (see 3.1.2). 
Expression of soluble proteins is just the first step in protein production. The proteins also need 
to be purified and stored at conditions that prevent aggregation. Finding the adequate conditions 
to keep a protein soluble can be a delicate process as it is often protein dependent. 
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diluting the purified protein to avoid molecular crowding can keep it from aggregating (36-38). 
Factors like pH and ionic strength also have to be adjusted (39, 40, 42, 43). 
Buffer systems provide a tight control of pH but their composition has to be chosen carefully 
to not provoke aggregation. For instance, phosphate buffer has been reported to promote 
protein aggregation (179, 180). The use of additives such as sugars and surfactants at low 
concentration can help to limit aggregation (181). Proteins are often stored at low 
temperature since high temperature promotes aggregation (44, 45) but a recent study showed 
that low temperature can also induce aggregation of some proteins (182). Freezing can be 
detrimental for protein solubility because it induces local hyper concentration of proteins and 
pH changes in some buffers (181, 183, 184). Moreover, repeated freeze/thaw cycles have been 
shown to increase aggregation (181). When the storage in solution is impractical, lyophilization 
can help but the process might also favor aggregation (185, 186). 
 
3.2 SOLUBILITY TAGS 
An efficient method to circumvent the formation of inclusion bodies and subsequent 
purification under denaturing conditions is the use of solubility tags (187-190). In this 
approach, the protein of interest is genetically engineered in fusion with a tag, which may 
enhance the expression, folding and solubility. Typically, the tag stabilizes the protein without 
altering its structure and function, and also facilitates downstream purification under non-
denaturing conditions. Ideally, the tag should be readily removable by proteolysis and be 
applicable to a wide range of proteins. Various kinds of solubility tags are currently used for 
protein expression (Table 3). For example, the N-utilization substance A (NusA) slows down 
transcription by inhibiting the RNA polymerase (191). Since transcription and translation are 
coupled in prokaryotes, Nus A increases the solubility of its partner by slowing down the 
translation process, and thus, gives more time to its partner to fold properly (192). The 11.5 
kDa thioredoxin (Trx) is another alternative as it might confer its thermal stability and high 
solubility in the E. coli cytoplasm to its fusion partner and also aid in the correct formation of 
disulfide bonds (193). Many solubility tags, Nus A and Trx included, need to be fused with 
small affinity tags such as a histidine tag in order to be purified. Other tags, like the maltose 
binding protein (MBP) or gluthathion-S-transferase (GST), possess both solubility enhancing 
properties and binding to specific ligands (175, 194, 195). However, GST performs poorly in 
E. coli due to its tendency to form homodimers (175). It is not clear how MBP operates but it 
is suspected to stabilize proteins long enough to give time for chaperones to assist folding (196). 
A major drawback of MBP and Nus A is that they can inflict a metabolic burden on the host 
expression system due to their high molecular weights.  
In order to prevent interferences with the biological function or the structure determination of 
the protein, a protease cleavage site is engineered between the protein and the solubility tag. 
After successful purification of a soluble fusion protein, the tag is released proteolytically and 
captured by a second round of purification.  
   
 
Table 3: Overview of the features of commonly used solubility tags compared to NT*. Adapted with permission from Waugh. 2005: Elsevier, Trends in Biotechnology,  
(188), © 2005 and Kimple et al. 2013 (190) with permission of the publisher. 
Name Origin Organism Size (kDa) Advantages Limitations References 
MaSp NT* MaSp Euprosthenops australis 13.9 
Thermostable 
High refolding capacity 
Small size 
Not an affinity tag Papers III, IV 
FlSp NT* FlSp Nephila clavipes 13.8 
Thermostable 
High refolding capacity 
Small size 
Supercharged 
Not an affinity tag Papers II, V 
Nus A N-utilization substance Escherichia coli 55 
Efficient translation initiation 
Slows down translation 
High metabolic burden 
Not an affinity tag 
(192) 
MBP Maltose binding protein Escherichia coli 40 
Efficient translation initiation 
Affinity tag 
Mild elution conditions 
Cheap affinity resin 
May stabilize protein during folding 
High metabolic burden (197) 
16 
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Name Origin Organism Size (kDa) Advantages Limitations References 
GST Glutathione-S-transferase Schistosoma japonicum 26 
Efficient translation initiation 
Affinity tag 
Mild elution conditions 
Cheap affinity resin 
High metabolic burden 
Homodimer 
Poor solubility enhancer 
(198) 
Trx Thioredoxin Escherichia coli 12 
Efficient translation initiation 
Promote disulfide bonds 
Thermostable 
Small size 
Not an affinity tag (193) 
SUMO Small ubiquitin modifier Homo sapiens 11.5 
Cleavage by SUMO protease 
Cleavage leave native N-terminus 
Small size 
Endogenous SUMO proteases 
Not an affinity tag 
(166, 199) 
PGB1 Protein G B1 domain Steptoccocus sp 7 Small size Not an affinity tag (200) 
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A clear advantage of the small ubiquitin modifier (SUMO), a 100 residue-long protein involved 
in regulation of transcription and protein transport, is that it does not require further engineering 
as it is efficiently recognized and cleaved by the SUMO protease (166, 201).However, the use 
of a SUMO tag is not applicable in eukaryotic systems as the SUMO protease is produced 
endogenously by these hosts. The immunoglobulin binding domain B1 from streptococcal 
protein G (PGB1) is advantageous compared to tags that need to be removed, as its small size 
(7 kDa) allows it to remain in fusion with the protein during structural studies (175). 
Comparison of solubility tags are often performed on small set of proteins with a wide range 
of properties and it is therefore difficult to draw a general and reliable conclusion on the 
performance of each tag. The efficiency of a tag highly depends on the nature of the protein of 
interest and the solubility-enhancing effect must be determined experimentally in each case. 
Some proteins are still not readily expressed and purified despite the now available array of 
fusion tags, and therefore, there is a need to develop tags with improved properties. 
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4 SCOPE OF THE THESIS 
 
The general aim of this thesis is to increase the understanding of spidroin fiber assembly and 
develop a biotechnological tool which addresses the struggles encountered during the 
production of protein-based products. The overall hypothesis is that the innovative use of the 
natural function of NT improves the production of aggregation-prone therapeutically relevant 
proteins. 
More specific aims of the thesis are to: 
¨ Increase the understanding of spidroin fiber assembly by determining the molecular 
mechanisms that mediate dimerization of NT (Papers I and II), and investigate if these 
mechanisms are conserved in distantly related NTs.  
 
¨ Based on the findings in Papers I and II, harness the biological role of NT in the design of 
a new biotechnological tool (NT*) for expression of different aggregation-prone biological 
drug candidates and other biomedically relevant proteins (Papers  III, IV and V). 
 
¨ Investigate if NT* can be used to control the aggregation of designed and disease-relevant 
amyloid proteins and facilitate studies of the aggregation mechanisms (Papers IV and V). 
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5 METHODOLOGY 
 
5.1 HETEROLOGOUS PRODUCTION OF PROTEINS IN E. COLI 
 
5.1.1 Expression  
Gräslund et al. reviewed the technical parameters to take into consideration for a successful 
expression and purification of proteins (202).There is a wide range of genetically engineered 
E. coli strains to choose from to produce proteins. Some strains can provide an oxidative 
environment inside the cells to promote the formation of disulfide bonds while others can assist 
the soluble expression of toxic and/or aggregation-prone proteins by co-expressing chaperone 
proteins or by tightly regulating expression with an inducible promoter.  
Regulation of a strong promoter like the T7 promoter requires that the bacterial strains harbor 
a gene coding for the T7 RNA polymerase. The expression of this polymerase is under the 
control of the lac operon that is induced by lactose, which binds the lac repressor and detach it 
from the T7 promoter to make room for the T7 RNA polymerase. This induction is also 
accompanied by the expression of the b-galactosidase that metabolizes and depletes lactose in 
the expression system. The isopropyl beta-D-1-thiogalactopyranoside (IPTG) – a lactose 
analogue – is hence employed as an expression inducer instead. Since IPTG cannot be 
metabolized by the b-galactosidase, it provides a constitutive induction. Typically, protein 
expression is induced at a bacterial optical density of 0.5-1 at 600 nm, in order to maximize the 
protein yield. This range of optical density represents the mid-to-late log-phase of cell growth 
where the bacteria grow exponentially before entering the stationary phase. Additionally, the 
temperature and the duration of expression have to be optimized (see chapter 3.1.1). 
 
5.1.2 Purification of proteins 
Recombinant proteins must be isolated and purified from the endogenous proteins of E. coli or 
other expression hosts, and they must be kept in solution in order to allow subsequent 
experiments. In addition to adjusting the experimental conditions as described in chapter 3.1.1, 
experimentalists must carefully choose the methods of purification. The first step in protein 
purification is the extraction of proteins from the host cells. Bacteria can be lysed with chemical 
treatment (e.g. detergent), enzymatic treatment (e.g. lysozyme) or mechanical actions (e.g. 
sonication, application of high pressure) (202). The method employed to lyse the cells can 
affect the protein yield and purity. Moreover, the disruption of the bacterial wall releases 
endogenous proteases that may degrade the overexpressed proteins. The addition of protease 
inhibitors, during the lysis step, prevents enzymatic degradation of proteins.  
  
 21 
 
Figure 4: Schematic representation of the NT* fusion protein constructs used in Papers III, IV and V. 
 
The second step of protein purification is to isolate the protein of interest. After lysis, the 
soluble proteins are separated from cell debris and insoluble proteins by centrifugation. Affinity 
columns like in immobilized metal affinity chromatography (IMAC) efficiently capture 
proteins from the centrifugation supernatant provided that they possess an affinity tag. In our 
experimental set-up, the constructs were designed to contain a solubility tag preceded by a His6 
affinity tag and followed by a protease recognition site before the protein of interest (Figure 4). 
IMAC may result in the co-purification of contaminant proteins if the level of overexpressed 
protein is low. This problem is addressed by submitting the sample to specific proteolysis 
between the solublity tag and target protein, followed by a second application of the sample to 
IMAC. This removes contaminants since the released target protein will pass through, while 
the solubility tag coupled to His6 and the contaminants bind to the column. If the contamination 
persists or if the protein cannot be captured by IMAC, alternative chromatography methods 
can be used. These methods take advantage of the protein properties and encompass other 
affinity chromatography (e.g. antibodies, ligands), ion exchange (charge), size exclusion (size 
and shape, see chapter 5.3.1), reverse phase and hydrophobic interaction (hydropathy) 
chromatography. As a mean to obtain a high protein yield, each method must be fine-tuned 
according to the properties of the protein of interest. Janson reviewed in ref 203 the 
fundamentals of each chromatography methods (203). 
 
5.2 CHARACTERIZATION OF PROTEINS BY SPECTROSCOPIC METHODS 
Spectroscopic methods are used for studying the response of molecules to electromagnetic 
radiation stimuli. From the data generated by these methods, experimentalists can quantify 
proteins or infer information on the structure of a protein of interest. Spectroscopic methods 
were used in all the constituent papers of this thesis.  
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5.2.1 Absorption spectroscopy 
Absorption spectroscopy, described in ref 204, achieves the quantification of protein (204). 
This technique exerts a direct measure of absorption based on the ability of tryptophan (Trp) 
and tyrosine (Tyr)  to absorb the energy of a photon. The aromatic rings of their side chains act 
as chromophores and at 280 nm, Trp absorbs more light than Tyr. A spectrophotometer is used 
to measure the absorption of a sample, and consists of a light source emitting a beam that passes 
through a monochromator which sorts and isolates the desired wavelengths. The incident light 
of intensity I0 goes through the sample and is transmitted to a detector placed in the axis of the 
light at an intensity I < I0 as a result of the energy loss during absorption. A sample holder with 
neglectable absorption, such as quartz or acrylic cuvettes, must be used to ensure that the 
absorption observed is solely due to the sample. The absorbance A is determined by equation 
(i): (i)	A = 	 log*+ ,+,  
The molar concentration C of proteins can then be calculated using the Beer-Lambert law (ii), 
using the path length of the sample holder (l) and the molar extinction coefficient (e) which is 
specific to the molecule and depend on the type and number of aromatic residues. (ii)	A = 	e	 × 	.	 × 	/ 
When Trp and Tyr are absent, the protein is “invisible” to the spectrophotometer and 
colorimetric methods, like the bicinchoninic acid assay (BCA), can be used to determine 
concentration. BCA relies on the ability of a dye (bicinchoninic acid) to detect Cu+ generated 
by the reaction of Cu2+ with peptide bonds. This method is highly sensitive since it can detect 
proteins in a range of 20-2000 µg/mL but its accuracy is limited. The assay is also relatively 
time-consuming as it takes at least 30 min, compared to the quasi-instantaneous results given 
by a spectrophotometer. 
 
5.2.2 Fluorescence spectroscopy 
Fluorescence is the emission of a photon by an excited fluorophore. As for absorbance, the 
fluorescent properties of proteins depend on the aromatic side chains of Trp, Tyr and to a lower 
extent Phe. Typically, the fluorophore in the sample is at electronic ground state (low energy 
level) and transitions to an excited state (high energy level) when it is hit by a photon at a 
wavelength of 280 nm. The excited state possesses different energy levels of vibrational states. 
The energy of the excited fluorophore partially dissipates by heat transfer to the solvent and 
the fluorophore reaches the lowest vibrational state. As the fluorophore cannot return to the 
ground state by losing more energy as heat, it emits a photon in the visible light spectrum, i.e. 
with a lower energy than the photon initially absorbed by the fluorophore. Fluorescence is 
measured with a spectrofluorometer, which has a similar design as a spectrophotometer except 
that the detector it is disposed at 90° with respect to the light source, and it includes an 
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additional monochromator between the sample and the detector. The principles of fluorescence 
spectroscopy are explained in ref 205 in greater details (205). 
Fluorescence spectroscopy is particularly appropriate for proteins containing aromatic residues 
that conveniently relocate from a buried location into a solvent exposed one, and vice versa, 
upon conformational changes. The fluorescence of aromatic residues decreases and shifts to a 
longer wavelength (higher energy) when it transitions from a hydrophobic environment to a 
polar one. The high sensitivity of fluorescence to changes of polarity in the local environment 
of the fluorophore makes fluorescence spectroscopy a suitable tool to study protein 
conformational changes, stability and folding/unfolding in a dynamic system.  
 
5.2.3 Circular dichroism spectroscopy 
Circular dichroism (CD) spectroscopy, described in ref 206, mainly gives information on the 
overall secondary structure of proteins (206). This technique is based on the absorption of 
circularly polarized light by the amide group of the peptide bonds. Because proteins are chiral, 
the absorption of left and right circularly polarized light is unequal and the difference of 
polarization between incident and transmitted light is elliptic. The ellipticity spectrum in the 
far-UV range is characteristic of distinct secondary structures. CD is an excellent tool to 
monitor protein/unfolding events and conformational changes induced by the modification of 
the environment, and to generate kinetic and thermodynamic information. However, CD is 
largely a qualitative method and although the contents of secondary structure of a protein can 
be calculated accurately for proteins with one type of secondary structure, it is more difficult 
for proteins with a mixture of secondary structures. 
  
5.2.4 Nuclear magnetic resonance spectroscopy 
Nuclear magnetic resonance (NMR) is together with X- ray crystallography and the recently 
emerging cryo-electron microscopy technique the most used method that can give structural 
details at the atomic level. The technique (described in ref 207) is based on the ability of 
atomic nuclei with a quantum spin and placed in a strong magnetic field, to respond to a weak 
oscillating electromagnetic field by absorbing electromagnetic energy (resonance) at different 
frequencies (207). The spin is an intrinsic property of nuclei with unpaired protons or neutrons 
and can be described by a rotation. This rotation is necessary to generate a magnetic moment 
as nuclei with a spin can absorb photons. The frequency of the photon is proportional to the 
gyromagnetic constant g – a parameter specific to each nucleus – and the strength (B0) of a 
given external magnetic field (iii). 
(iii) 2pn	 = 	1+	. g 
Most NMR experiments are designed for nuclei with a spin number of ½ such as the isotopes 
1H, 13C or 15N. In the presence of an external and static magnetic field, the nuclear spin can 
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adopt either a ground state that is parallel to the magnetic field or a higher energy state oriented 
in the opposite direction of the magnetic field. At thermal equilibrium, the ground state is the 
most populated and in order to generate an NMR signal, the equilibrium must be disturbed. In 
order to do so, electromagnetic radiations with low radiofrequency, matching the energy 
difference between the ground state and the higher energy level, are applied to the sample for 
a short time. This energy transfer is called resonance, and is defined by the product of a photon 
frequency of oscillation (n) with the Plank constant (h) (iv). 
(iv) 3	 = 	ℎ	. n 
The energy difference between the two spin states is difficult to detect because it is very small, 
but it can be increased with a magnetic field. Linking equation (iii) and (iv) shows that the 
resonance of a given nucleus depends on the strength of the magnetic field (v). Consequently, 
the stronger the magnetic field, the bigger is the energetical transition between the two states. 
(v) D3	 = 	ℏ	. 1+	. g 
The diversity of the electromagnetic surroundings of nuclei in a complex molecule allows to 
differentiate individual spins from each other. Electrons create local magnetic fields shielding 
the nuclei from the external magnetic field, and nuclei resonance at different frequencies in 
return. For instance, a proton bound to a nitrogen will have different resonance frequency than 
a proton bound to a carbon since the former atom is more electronegative than the latter. A 
difference in signal dispersion is also observed for the protons involved in different type of 
secondary structures. This shielding effect is called a chemical shift as the resonance frequency 
is shifted compared to the value for a standard molecule. The high number of nuclei in a protein 
renders the determination of three-dimensional structure by NMR complex due to spectral 
overlap in 1D-experiments. Multidimensional spectroscopy, using the NMR active nuclei of 
1H, 13C and 15N, reduces the risk of overlapping signals. For instance, the hetero single quantum 
coherence (HSQC) experiment is a 2D NMR spectrum, which provides a “finger print” of the 
protein. In an HSQC experiment, the magnetization is transferred from 1H to a heteronucleus 
(the term refers to all atom except protons, usually 13C and 15N). The resulting spectrum 
displays one peak for each proton bound to a heteronucleus and gives indications on the fold 
of the protein. A folded protein has well-dispersed peaks and each residue is distinguishable 
but the dispersion of the spectrum becomes narrower and peaks overlap when the protein 
unfold. 
For protein structure determination, first the spectral peaks are assigned. Then the internuclear 
distances are determined with experiments based on the nuclear Overhauser effect (NOE), 
which transfer magnetization through space. Neighboring nuclei reacting in consequence of 
this perturbation can, therefore be identified. Typically, nuclei within a perimeter of 5 Å exhibit 
a measureable NOE. The double labeling with 13C and 15N facilitates backbone assignments of 
larger proteins. From a set of spatial information, spectroscopists try to satisfy as many 
constraints as possible (dihedral angles, interatomic distances, etc.) during structure calculation 
but they can only estimate an ensemble of conformers because the distance constraints are not 
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precise enough. The accuracy of the structure calculation is given by the root-mean-square 
deviation (RMSD) of the atomic coordinates. The smaller the RMSD, the more accurate is the 
structure determination. The advantage of NMR spectroscopy is that NMR gives information 
on the dynamics of the proteins in addition to structural information.  
NMR is a non-destructive and highly reproducible method provided that some conditions on 
the sample are met. The proteins are typically labeled during recombinant expression in 
minimal media supplemented with labelled sources of carbon and/or nitrogen (glucose and 
ammonium chloride, respectively) in order to incorporate the isotope labels. The proteins must 
be soluble and highly pure to prevent interferences in signal from the contaminants of the 
expression host. The sample is analyzed in aqueous solution, often in phosphate buffer. 
Alternative solutions consisting of a mixture of organic solvents, detergents or lipids, can be 
used for the analysis of proteins with a poor solubility in water. In order to acquire a strong 
signal, often protein concentrations in the millimolar range are desirable to reduce the noise-
to-signal ratio. Obtaining a high concentration of aggregation-prone proteins is difficult to 
achieve as they will eventually fall out of solution given the long handling time necessary to 
record a set of spectra. For this reason, some proteins can only be analyzed in fusion with a 
solubility tag. Lowering protein concentration and/or temperature is also a way to overcome 
the aggregation issue. Although this method gives more structural information than the other 
spectroscopic methods described above, NMR experiments are time consuming and a set of 
experiment for structural determination can take up to days depending on the concentration of 
the sample. 
 
5.3 EVALUATION OF PROTEIN QUATERNARY STRUCTURE AND 
AGGREGATION  
 
5.3.1 Size exclusion chromatography 
Size exclusion chromatography (SEC) – also called gel filtration – is both an analytical and a 
purification tool (203). A protein sample applied to SEC passes through a column with an inert 
resin composed of porous beads. The molecules in the sample penetrate the pores of different 
sizes and their migration is delayed to varying degrees by the passage through channels in the 
beads. On their pathways down the column, the retention time of the proteins is inversely 
proportional to their hydrodynamic radius, that is their shape and size. The shape of proteins 
cannot be deduced from SEC data and only an apparent molecular weight is estimated based 
on the calibration with a set of proteins standards. This estimation is not always accurate 
because the standards may have different conformations and properties compared the proteins 
of interest despite a similar molecular weight and, therefore, the elution profiles may differ. 
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Analytical SEC is employed to investigate protein size, association and aggregation. The wide 
range of buffers and conditions compatible with SEC allows for a good separation of 
monomeric proteins from larger oligomer species. 
 
5.3.2 Mass spectrometry 
Mass spectrometry is a sensitive analytical method that allows quantification and identification 
of molecules (208). The method can also give structural information. Mass spectrometry 
detects ions, separates them according to their mass-to-charge-ratio and provides their relative 
abundance. Molecules in solution transferred to the gas phase by electron ionization provokes 
extensive fragmentation of macromolecules. 
Softer methods like electronspray ionization mass spectrometry (ESI-MS) were developed to 
overcome unsolicited fragmentation. In ESI, electrically charged droplets are generated thanks 
to a strong electric field that is applied on a sample in solution at the outlet of a capillary. The 
solvent of the droplets evaporates through their interaction with a drying gas (e.g. nitrogen) and 
as the concentration of charges gradually increases, the dielectric forces generated by the 
charge repulsion exceed the surface tension holding the droplets together. Consequently, the 
droplets explode and the ions are ejected into the gas phase. ESI-MS allows identification of 
non-covalent protein-protein interactions; however, it requires samples with high purity since 
contaminants can generate background noise, overlapping with the signal of the protein of 
interest. 
Structural information can be obtained from hydrogen deuterium exchange mass spectrometry 
(HDX-MS) (209). This method takes advantage of the constant proton exchange between 
amide groups of the protein backbone and the solvent. HDX-MS detects the changes in mass 
ensuing the exchange of a proton from the amide backbone for a deuterium from a deuterated 
solvent. The rate of exchange depends on secondary structure (hydrogen bonding of the amide 
proton) and the accessibility of the different protein parts to solvent. For example, the residues 
involved in stable secondary structures or those buried in the hydrophobic core of the protein 
have a lower exchange rate than disordered and surface exposed residues. Thus the 
proton/deuterium exchange rates can give information on secondary structures, location of 
binding sites in protein-protein interactions, and overall protein structure and dynamics. 
 
5.3.3 Investigating amyloid aggregation with Thioflavin T fluorescence 
Thioflavin T (ThT) is a benzothiazole dye with the ability to bind amyloid aggregates and then 
fluoresce at 482 nm when excited at 450 nm. ThT is thought to intercalate between the side 
chains that are solvent-exposed and parallel to the fibril axis, and its fluorescence augments 
with an increased fibril mass. Due to this special feature, ThT is commonly used as a probe to 
monitor amyloid fibrillization kinetics in vitro (210). 
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6 RESULTS & DISCUSSION 
 
6.1 DIMERIZATION MECHANISM OF MASP NT 
The production of artificial silk-based material is appealing due its broad spectrum of potential 
applications. However, efforts to produce artificial silk equaling the properties of natural spider 
silk in a reproducible manner have so far been largely unsuccessful. This is partly due to the 
limited understanding of the biological events governing the assembly of spider silk proteins. 
For instance, the monomer/dimer interconversion of NT controls the solubility and storage of 
spidroins and their assembly into fibers but the detailed molecular mechanisms driving this 
process were largely unresolved at the start of this thesis project. In order to gain more 
comprehension of the underlying mechanisms of the dimerization of NT, we characterized the 
NT domain of MaSp from the spider Euprosthenops australis – herein referred to as MaSp NT. 
The most important findings are summarized in the next sections and a detailed account of the 
results are found in Paper I. 
 
6.1.1 Structure of the dimer 
Aside from the dimer structure of MaSp NT obtained by crystallography at pH 7.0 (141), the 
information on MaSp NT dimers were obtained with spectroscopic methods that provide details 
on the dynamics of the domain with respect to pH but little information on its structure. The 
crystal structure of the dimer is somewhat unexpected considering later reports pointing to 
monomers at neutral pH and dimers only at lower pH (143-147) In Paper I, structural 
characterization of MaSp NT by NMR spectroscopy revealed a dimer at pH 5.5 (Figure 5A) 
that was highly similar to the crystal dimer as reflected by the low RMSD of 1.15 Å when both 
structures were superimposed. On the basis of the crystal dimer structure, the Asp 40 and Glu 
84 interacted in a so called handshake and it was suggested that these residues could be 
involved in the pH sensitive relay that controls dimerization (141) but this handshake 
interaction was absent from the NMR dimer structure. Possible explanations are that either the 
NMR data are insufficient to allow definition of the distance between the two residues, and/or 
the handshake interaction is transient and only detected in a conformer captured in the crystal, 
while it is averaged out in the NMR structure ensemble.  
 
6.1.2 Molecular mechanism of dimerization 
Identifcation of residues involved in the dimerization process of MaSp NT were based on a 
large set of site-directed mutations. As the transition point of dimerization was estimated at pH 
6.4, a histidine (His 6) –which has a pKa around 6 – was expected to be a key residue for the 
process, but its deletion did not show any effect on the dimerization (141).. In a computational 
analysis of MaSp NT, Wallace & Shen identified Asp 39, Asp 40, Arg 60 and Lys 65 (shown 
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in Figure 5A) – as the residues capable of stabilizing the dimer via the formation of salt bridges 
(150). These conclusions were supported experimentally with mutations disrupting the salt 
bridge. The substitution of Arg 60 or Lys 65 for Ala destabilized the dimer (145), and the 
substitution of Asp 39 or Asp 40 for asparagines (Asn) prevented MaSp NT dimerization (141, 
145).The presence of a salt bridge between Asp 40 and Lys 65 observed in the crystal dimer of 
MaSp NT was confirmed by the NMR data in Paper I. In order to better understand the role of 
the salt bridge, we performed site-directed mutagenesis where these residues were either 
substituted with neutral residues or with residues of the opposite charge. Both sets of mutations 
stabilized the monomer and these findings further establish the role of Asp 40 and Lys 65 in 
mediating the association of monomers into dimers. 
 
 
Figure 5: NMR structure of (A) MaSp NT dimer (PDB ID: 2LTH) (Paper I).The salt brigde formed 
by Asp 40 and Lys 65 is highlighted by an orange circle and protonated glutamates during 
dimerization are shown in stick representation. NMR structure of (B) MaSp NT monomer (PDB ID: 
2LPJ) (151), and (C) FlSp NT monomer (accession code pending, Paper II). The charged residues 
and the residues involved in the dimerization process are shown in stick representation.  
 
The cluster formation of acidic residues, which can increase the pKa values of their side chains 
(2), and the pH dependence of the dimerization of NT imply that titratable acidic residues are 
participating in the process but the experimental efforts employed so far could not identify all 
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the residues involved. Although they are not surface exposed, Glu 79 and Glu 119 were 
considered for investigations. The mutation of Glu 119 to Gln – simulating a constitutive 
protonated state with the amide of the side chain acting as a hydrogen donor – stabilized the 
dimer conformation (145), and a dimer was likewise identified by mass spectrometry at both 
high and low pH when the Glu 79 was replaced by Gln (144). In agreement with these results, 
molecular dynamic simulations singled out E79 and E119 as potential candidates for 
protonation (150). 
In Paper I, we hypothesized that several residues are acting as a pH sensitive relay and that the 
effect of their protonation is cumulative. We first designed a double mutant where both Glu 79 
and Glu 119 were replaced by Gln (MaSp NTE79Q/E119Q), and we showed that the 
monomer/dimer equilibrium was significantly shifted towards the dimer although the dimer 
state was not fully reached. Therefore, another residue was thought to be involved to fully 
associate the monomer subunits. Glu 84 was deemed a good candidate to complete the 
protonation pattern because it is relatively well conserved among NTs. The dimer was further 
stabilized with the addition of the Glu 84 to Gln mutation (MaSp NTE79Q/E84Q/E119Q) and similar 
HSQC NMR spectra were observed for the wt MaSp NT dimer and MaSp NTE79Q/E84Q/E119Q 
although the latter was analysed under conditions that favor the monomer conformation (high 
pH and salts). The estimation of proton uptake from the Trp fluorescence data suggested that 
wt MaSp NT captures 3 protons upon dimerization while MaSp NTE79Q/E84Q/E119Q did not pick 
up any proton, confirming that the dimer conformation was locked in the triple mutant. 
Interestingly, the protonation proceeds gradually during dimerization because the pH of Trp 
fluorescence interconversion is 6.5 but the last protonation occurs at pH 5.7. The shift of 
NTE79Q/E119Q towards a more dimeric population is indicative of that the titration of Glu 79 and 
Glu 119 is the first step of protonation required for dimerization to occur at pH 6.5. It has not 
been determined experimentally whether it is the protonation of Glu 79 or Glu 119 that happens 
first but the slightly more elevated theoretical pKa of Glu 79 (150) suggests that Glu 79 is 
protonated first. Their close pKa values suggest that these protonation events happen in quick 
succession or in parallell. 
The role of Glu 84 is ambiguous because its individual mutation promoted the monomer 
conformation (141, 145) while the mutation had an opposite effect when it was part of MaSp 
NTE79Q/E84Q/E119Q. It is possible that the charged Glu 84 at first interacts electrostatically with 
Arg 60 and Lys 65 to promote the interaction between two monomer subunits and the 
subsequent protonation of this residue in the partially stable dimer strengthens the association. 
An indirect effect on the dimerization also appears likely considering that the mutation of Glu 
84 removes a charge in the cluster of negative charges. The charge removal might result in 
decreased pKa of the surrounding charged residues, lowering, de facto, the pH at which 
dimerization occurs. 
In summary, we established in Paper I that the dimerization of MaSp NT is initiated by the 
electrostatic interaction between monomers as mediated primarily by Asp 40 and Lys 65 
(Figure 6). The pKa of Glu 79 and Glu 119 becomes elevated when the two subunits are getting 
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closer and this leads to their protonation upon lowering the pH below 6.5. The resulting dimer 
is partially stable and requires the protonation of Glu 84 to be locked in a fully stable 
conformation. Our findings offer biologically relevant insights on how spiders tightly control 
the dimerization of NT to manage their silk formation. Precocious aggregation of the spidroins 
is avoided by keeping NT in its monomer conformation during storage and their fast assembly 
into fibers is promoted when NT dimerizes. In vitro characterizations of an NT only (ie without 
repetitive parts) do not necessarily reproduce its biological role in the gland where NT is 
connected to the large repetitive parts and present at high concentration. However, it was 
suggested that NT dimerization is concentration independent (145, 149), and we discovered in 
Paper I that the interconversion from monomer to dimer is also observed by Trp fluorescence 
spectroscopy on a construct where MaSp NT is in fusion with 5 repeats of the central region. 
Taking these results into consideration, it is tempting to speculate that NT dimerization as 
described here would only be marginally different in the context of the gland.  
 
 
Figure 6: Proposed mechanism for MaSp NT dimerization. (A) MaSp NT molecules with a monomer 
conformation. (B) Electrostatic interactions mediated by D40, K65, R60 and possibly E84. (C) partially 
stable MaSp NT dimer after the protonation of E79 and E119 around pH 6.5. (D) Fully stable MaSp NT 
dimer after the protonation of E84 around pH 5.7. Reproduced from Paper I. 
 
In the light of our results, we suggest that both micelles and a liquid crystalline state can occur 
during storage of spidroins in the gland (123-126). It is possible that both organizations exist 
at different locations of the gland. We hypothesize that the spidroins are first arranged in 
micelles where NT is mainly monomeric and interact with other subunits with transient 
electrostatic interactions. At the entrance of the duct, NT forms partially stable dimers that pre-
align the spidroins, possibly in a liquid crystalline arrangement. The pre-alignment enables the 
rapid conversion of the spidroins into fibers when they proceed down the duct, while structural 
rearrangement of the spidroins still can occur, and provides a safety mechanism against 
precocious aggregation. As pH keeps dropping, NT dimers are further stabilized and 
interconnect the spidroins which allows propagation of pulling forces through the polypeptide 
chain and facilitates the structural conversion of the repetitive parts.  
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6.2 A CONSERVED MECHANISM ACROSS SPECIES AND SILK TYPES 
Spiders and their silk are the product of million years of evolution (211), but yet, the NT domain 
of the spidroin remains highly conserved (117, 118, 131, 134). This suggests that NT has a 
conserved function and raises the question whether this function is mediated by the same 
mechanism through spider species and silk types. The NT domain of the flagelliform spidroin 
(FlSp) from the spider Nephila clavipes – herein referred to as FlSp NT – caught our attention 
because it shares only 35% sequence identity with the MaSp NT of E. australis studied in Paper 
I. This degree of sequence identity is so low that three-dimensional structural similarity can not 
be taken for granted based on sequence identity only. Moreover, FlSp NT lacks the 
characteristic Trp of MaSp NT at position 10, which is thought to drive the conformational 
switch of MaSp NT during dimerization (146). We asked ourselves what the implications of 
these differences are on the behavior of FlSp NT. In Paper II, we investigated the dimerization 
mechanism of FlSp NT to determine if it is governed by the same mechanism as MaSp NT 
despite their distant evolutionary relationship.  
We found that wt FlSp NT form a dimer upon lowering the pH and the determined NMR 
structure revealed a close structural similarity to the MaSp NTs from E. australis, N. clavipes 
and Latrodectus hesperus, and MiSp NT from Araneus ventricosus with a three-dimensional 
structure organized as a dipolar 5-helix bundle (152, 212, 213). Unlike the aforementioned 
NTs, FlSp NT has a buried Phe at position 10 instead of a Trp. The more hydrophobic nature 
of Phe compared to Trp raises the question whether the helices rearrange during dimerization 
and expose the Phe to solvent, as for Trp in MaSp NT. In Paper II, we introduced a Trp at 
position 10 (NTTrp) by site directed-mutagenesis. The Trp fluorescence analysis of the FlSp 
NTTrp exhibited a sensitivity to pH demonstrated by the decrease in fluorescence amplitude at 
pH < 6.8. However, the response to pH was not accompanied by a major rearrangement of the 
helices since no shift in the fluorescence wavelength was observed. Trp fluorescence is 
typically quenched by neighboring protonated acidic side chains but there are no acidic groups 
in the vicinity of Trp 10 in FlSp NT (Figure 5C). Therefore, it is more plausible that Trp is 
already solvent exposed in the monomer, because it does not fit the shallow pocket normally 
hosting a less bulky Phe, and the dimerization provokes a structural rearrangement that moves 
Trp 10 close to a protonated residue. Our data indicates that having a wedged Trp swinging out 
from a buried position is not a prerequisite to toggle the conformation of NT during 
dimerization. It has been recently suggested that plasticity from the presence of Met residues 
drive the conformational changes of NT (147). 
The absence of Trp in wt FlSp NT renders the monitoring of dimerization with Trp fluorescence 
spectroscopy impossible. By designing site-directed mutants previously used for the 
characterization of MaSp NT, we used the same methods – fluorescence spectroscopy aside – 
to provide evidence that the electrostatic intermolecular interaction between Asp 40 and Lys 
65 that associate monomers into dimers is preserved in FlSp NT.  
   
  
Table 4: Table summarizing the molecular mechanisms identified for the dimerization process of NT from different silk types and species. Asp 39 and Arg 62 in MiSp 
NT correspond to Asp 40 and Lys 65 of MaSp NT. 
Silk type Species Salt bridge Protonation Structure Ref 
MaSp E. australis Asp 40 -Lys 65 
Glu 79 
Glu 84 
Glu 119 
 
Paper I, (151) 
FlSp N. clavipes Asp 40-Lys 65 Not identified 
 
Paper II 
MiSp A. ventricosus 
Asp 39- Arg 62 
Not investigated 
Glu 73 
Glu 79 
Glu 119 
 
(212) 
MaSp L. hesperus Not investigated 
Glu 79 
Glu 119 
Third residue was not 
identified 
 
(213) 
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The importance of the salt bridge between these two residues has also been highlighted in the 
MaSp NT of N.clavipes (152), and Otikovs and colleagues revealed the formation of a salt 
bridge between Asp 39 and Arg 62 (two residues corresponding to Asp 40 and Lys 65 of MaSp 
NT) in the dimer of MiSp NT. Although the role of Asp 40 and Lys 65 – and corresponding 
residues in MiSp NT – was not explored for the other characterized NTs, the residues are most 
likely as important in these NTs since the charges are well conserved at these positions. 
The characterization of FlSp NTE79Q/E84Q/E119Q in Paper II provided partly conflicting results. 
SEC suggested that FlSp NTE79Q/E84Q/E119Q undergoes a pH sensitive dimerization but ESI-MS 
indicated an inability to dimerize. The NMR data could rationalize these results since a mixture 
of dimer intermediates together with monomers were observed, which fits nicely with the 
selected-fit model proposed for NT association in a previous study (146). A similar 
intermediate conformation was observed for MaSp NTE79Q/E119Q in Paper I. NMR data showed 
that at high pH, the conformational equilibrium was shifted towards the monomer and that low 
pH promoted the formation of partially stable dimers but the resolution of SEC is too low to 
distinguish the high populated conformational state from the low populated one. ESI-MS of 
FlSp NTE79Q/E84Q/E119Q presumably dissociates loosely associated dimer intermediates.  
We were not able to identify all the residues responsible for locking the FlSp NT dimer in Paper 
II and the elucidation of a dimer structure will eventually shed light upon the uncertainties 
regarding what residues are protonated. The presence of dimer intermediates in 
NTE79Q/E84Q/E119Q illustrates that at least one of the Glu considered herein, possibly Glu 79 due 
to its strict conservation across all NTs, is implicated in protonation events. Both Glu 84 and 
Glu 119 might not be involved in the dimerization of FlSp NT and the orientation of the side 
chains located at the dimer interface in the monomer structure points to Glu 115, Glu 130 or 
Asp 122 as potential candidates for titration (Figure 5C). Interestingly, these residues have no 
corresponding residues in other studied NTs. In MaSp NT, Glu 84 is located in a loop and has, 
therefore, more flexibility to perform a dual role (handshake and electrostatic attraction 
between subunits), while in FlSp NT it is positioned at the end of helix 3 with less freedom to 
move. The molecular mechanisms of dimerization of MiSp NT from A. ventricosus and MaSp 
NT from L. hesperus are comparable to FlSp NT and MaSp NT (E. australis) with the 
implication of Glu 79 and Glu 119 in protonation events (Table 4) (212, 213). Nevertheless, 
Glu 84 does not play a role in the pH-dependent interconversion of MaSp NT from L. hesperus 
and the exact residue for its replacement has still not been discovered (213), whereas Glu 84 is 
simply absent in MiSp and its role is assumed by Glu 73 instead (212). In the primary structures 
of TuSp NTs, Glu 119 is replaced by a basic residue and no acidic groups are present near this 
position. For this reason, TuSp NTs are intriguing because they must involve a new set of 
residues to protonate for dimerization, provided that it takes place at all.  
Altogether, our findings validate a mechanism of dimerization of FlSp NT comparable to other 
studied NTs where electrostatic interactions followed by protonation events stabilize the dimer 
formation (Table 4), but it involves a new set of residues that are yet to be identified. Therefore, 
the role of NT as a pH sensitive relay and the overall mechanisms governing its dimerization 
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are likely to be conserved for most spiders. Babb et al reported that all silk glands produce, 
albeit at lower amounts, different spidroins than the ones that make up the bulk of their silk 
(131). The overall similar mechanisms for pH dependent dimerisation of different NTs, but 
based on different sets of residues, could imply that spiders have developed a mechanism that 
prevents hetero-assembly of co-existing different spidroins, but at the same time ensure that 
they homo-dimerise in the same pH range.  
 
6.3 NT* AS A SOLUBILITY TAG 
 
6.3.1 Development of NT* 
NT plays an important role in keeping the spidroins soluble at high concentration during storage 
in the gland. We wondered whether it is possible to exploit the solubility enhancing competence 
of NT for the development of biotechnological applications since protein aggregation is a major 
challenge for the elaboration of protein-based therapeutic approaches. The biotechnological 
tools and methods developed to address protein aggregation are not universal and need to be 
widened. Our investigations in Paper I and II showed that NT has a high thermal stability and 
folding capacity. These characteristics are desirable for the design of solubility tags. Knowing 
that NT enhances solubility in its monomer conformation, we investigated ways to disrupt the 
salt bridge and charge attractions between Asp 40 and Lys 65 since it is a prerequisite for the 
association of NT into dimers.  
In Paper III, we designed the double mutant MaSp NTD40K/K65D, denoted MaSp NT*. We 
exchanged the position of D40 and K65 and characterized the dimerization ability, structure 
and thermodynamic stability. Trp fluorescence spectroscopy showed that NT* does not 
dimerize between pH 5.0 and 8.0. SEC and NMR confirmed this result by showing 
chromatograms and spectra of NT*, respectively, consistent with a monomer at both pH. 
Denaturation experiments revealed that NT* is as stable as the wild type dimer over the whole 
pH-range as determined by CD. The solubility of the mutant domain is two-fold greater than 
the solubility of wt NT although the net charge of the domain is conserved. The constitutive 
monomer conformation of NT* may be due to the introduction of a positively charged residue 
in the NT negative pole, and vice versa, which creates a new intramolecular electrostatic 
interaction pattern, thereby weakening the intermolecular interactions that are required for NT 
dimerization and also significantly lowering the pKa of acidic groups in the cluster. 
 
6.3.2 A general tag for the production of aggregation-prone proteins of 
therapeutic relevance 
Inspired from how spiders store their silk proteins in a highly soluble manner, we evaluated in 
Paper III, the capacity of NT* to enhance the solubility of various aggregation-prone proteins 
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and peptides. The selected proteins, including the human cationic antimicrobial protein 18, the 
cholecystokinin 58 (CCK58), Ab1-40 and Ab1-42, are known to resist soluble expression in 
E. coli. NT* was preceded by a His6 tag to facilitate protein purification on a Ni-sepharose 
column and a cleavage site was engineered between the NT* and the protein of interest in order 
to remove the NT* solubility tag and allow isolaton of the target protein (Figure 4).  
 
 
Figure 7: Scheme summarizing the purification of aggregation-prone proteins using NT* as a solubility 
enhancer. Following overexpression, water-soluble proteins were purified by IMAC before proteolytic 
release of the protein of interest. Hydrophobic peptides formed micelles in fusion with NT* and were 
purified by salt precipitation and pure peptides were obtained after cleavage. 
 
Among the more thoroughly characterized proteins in Paper III was a recombinant fragment of 
the human pulmonary surfactant protein D (rfhSP-D). Native SP-D participates in the 
recognition of a wide range of pathogens and mediates immune responses by recruiting 
macrophages and neutrophils in the lungs (214). When previously expressed in E. coli, rfhSP-
D was recovered from inclusion bodies with denaturing agents and at low yield (215). In fusion 
with NT*, rfhSP-D was expressed in a soluble manner and at higher yield than in fusion with 
PGB1. RfhSP-D adopted a trimeric quaternary structure characteristic of its active 
conformation when released from the tag. 
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We developed an efficient non-chromatographic method to purify transmembrane peptides and 
we selected the very hydrophobic rSP-C33Leu and rKL4 as a proof of concept. The pulmonary 
surfactant proteins SP-B and SP-C lower the surface tension at the alveolar air-water interface, 
which prevents lungs from collapsing at end expiration (216-219). Native SP-C is a 4.2 kDa 
lipoprotein that is highly aggregation prone, and thus difficult to produce in aqueous solution, 
forming β-sheet aggregates and amyloid fibrils whereas it is mainly a-helical in a phospholipid 
environment (12, 13). Johansson and Curstedt developed SP-C33Leu – a designed analogue of 
native SP-C with a poly-leucine segment – which folds into a stable a-helical conformation 
due to the high a-helix propensity of leucine residues. In animal models of respiratory distress 
syndrome (RDS) – a condition engendered by prematurity or surfactant inactivation – a 
synthetic surfactant based on SP-C33Leu is functional (217, 220-223). A synthetic surfactant 
based on SP-C33Leu is currently in clinical trials for treatment of RDS in neonatal infants 
(224). KL4 is an analogue of SP-B developed to treat RDS (225, 226). The peptide is 21 
residues long and was designed with the motif Lys-Leu-Leu-Leu-Leu repeated four times. KL4 
is FDA approved as a component of an artificial surfactant preparation for the treatment of 
RDS (227, 228). Both KL4 and SP-C proved to be water-insoluble and difficult to produce 
recombinantly owing to the formation of inclusion bodies. 
After cell lysis and a centrifugation step to remove cell debris and other contaminants, the 
soluble fusion proteins were precipitated with NaCl. The subsequent pellets, pure from most 
E. coli contaminants that stay in solution, were resuspended in buffer and cleaved with 
cyanogen bromide to remove the solubility tag. Another salt precipitation step followed by 
centrifugation enabled isolation of the hydrophobic peptides which could then be resuspended 
in organic solvent. The procedure yielded up to 10 mg and 30 mg of pure rKL4 and rSP-
C33Leu, respectively. SEC and electron microscopy revealed that rSP-C33Leu and rKL4 form 
micelle-like structures when fused with NT*. This finding is in accordance with other studies 
suggesting that spidroins are stored in a highly soluble manner due to their organization into 
micellar structures with NT shielding the hydrophobic repetitive region from the aqueous 
environment (123-125). The structural integrity of rSP-C33Leu was confirmed by NMR 
spectroscopy and the recombinant peptide was functional in vivo in experiments using preterm 
newborn rabbits as RDS models. Purified proteins from bacteria might be contaminated by 
lipopolysaccharides that can induce an immune response if the protein is to be injected in an 
animal or for pharmaceutical use (229, 230). We have not observed such an issue in our 
experiments with rSP-C33Leu in premature rabbit fetuses, but further purification with 
endotoxin columns might be required. The results are summarized in Figure 7. 
The mechanisms by which NT promotes solubility remains to be established. In the same way 
as MBP (196), NT* might transfer its stability to the folding intermediate of the fused protein. 
The folding of wt NT is (60 µs) (146) and  given that NT* behaves similarly it acquires its 
three-dimensional fold as soon as it comes out of the ribosome during translation and its high 
stability can protect folding intermediates of the target protein from aggregating and give them 
more time to fold correctly. In addition, the intermediate size of NT* (about 14 kDa) has the 
advantage of not being a major metabolic burden for the host.  
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In summary of Paper III, we effectively produced a set of highly aggregation-prone peptides 
and proteins, and NT* gave up to 8-fold higher amounts of functional protein than commonly 
used solubility tags including MBP, Trx and PGB1 (Figure 8). Moreover, we developed an 
elegant and efficient method for the purification of hydrophobic peptides without 
chromatography based on salt precipitation. 
 
 
Figure 8: Comparison of protein yields obtained after IMAC purification of recombinant NT* or other 
solubility tags in fusion with (A) rSP-C33Leu, (B) rfhSP-D, (C) rKL4, (D) rCCK58, (E) rAb1-40 and 
(F) rAb1-42 
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6.3.3 A tag to study amyloidogenic proteins 
Due to their inherent pronounced tendency to aggregate, amyloid forming proteins are difficult 
to produce recombinantly. They are often found in inclusion bodies when overexpressed in E. 
coli and their ensuing purification is cumbersome. Furthermore, the shortage of systems 
exerting a tight control over their assembly jeopardizes experimental studies. In Paper IV and 
V, we explored the ability of NT* to control the aggregation and facilitate the study of 
amyloidogenic proteins. 
Previous attempts to express b17 recombinantly resulted in the formation of inclusion bodies 
and in precocious aggregation during in vitro experiments (11, 106). To evaluate our system, 
we fused b17 to MaSp NT* in Paper IV. NT*-β17 was successfully expressed in a soluble and 
stable form at neutral pH but fell out of solution at pH < 6.8, limiting structural studies of the 
fusion protein to neutral pH or above. HSQC NMR experiments revealed that β17 was 
unstructured in the fusion protein and might interact with the NT* tag by elecrostatic 
interactions. The polypeptide was characterized by CD spectroscopy after removal of the tag 
by proteolysis. β17 adopted a random coil conformation mixed with β-sheet structure at pH 8.0, 
whereas it formed β-sheets at pH 6.0 or in presence of increasing concentrations of calcium. 
Fibril formation kinetic assays using ThT as a reporter demonstrated that the fibrillation of β17 
is prevented in fusion with NT*. The tag could be efficiently cleaved, which allowed the β17 
protein to form ThT positive aggregates, without interference from released NT*. Nevertheless, 
transmission electron microscopy revealed that cleaved off β17 does not form amyloid fibrils 
but rather large amorphous aggregates at pH 8.0. We determined that the conversion from 
amorphous aggregates to fibrils only occurs at pH 6.0 or in the presence of salts. As an example, 
we showed that the NT* system enables interaction studies with anti-amyloid proteins, in this 
case Bri2 BRICHOS, to identify and evaluate potential drugs against fibril formation. The 
BRICHOS domain delays Aβ1-42 aggregation in vitro (231-234) and in vivo in a Drosophila 
melanogaster model (235, 236).  
In Paper IV, our findings on β17 structure are in line with results from other studies on Aβ and 
alpha-synuclein, which suggest that monomeric amyloid proteins are disordered (91, 94, 237). 
The promotion of β-sheets and amyloid fibril formation by slightly acidic pH or salts is also in 
accordance with the literature on amyloid proteins (238-240). In this study, we developed an 
efficient method to produce an amyloid protein in a heterologous host which enables 
experimental studies without precocious aggregation. 
In Paper V, we proposed a protocol to produce high amounts of Ab1-40 and Ab1-42 using the 
solubility enhancing performance of FlSp NT*. In Paper II, this mutant was developed in 
analogue to the MaSp NT* counterpart, from D40K/K65D mutations, as a control to study the 
monomer state of FlSp NT. We used it in Paper V with the rationale to investigate if this 
significantly more charged domain (25 charges vs 11 in MaSp NT) improves solubility 
enhancing properties or otherwise improves expression and purification. 
The amyloid peptides were solubly expressed and could be purified with a quick and cheap 
purification protocol yielding higher amount of monomeric Aβ than reported in the literature 
(241-243). Briefly, overexpressed NT*-Aβ was purified by IMAC in the presence of 8 M urea. 
The urea was removed by overnight dialysis while the amyloid peptides were released from 
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NT* proteolytically. The mixture of tag, peptide and protease was subjected to SEC to isolate 
monomeric peptide. In general, NMR characterization of proteins may be hampered by the low 
amount of isotope-labeled proteins obtained in minimal media and the production of proteins 
in appropriate amounts may prove to be expensive. Furthermore the incorporation of chemically 
modified residues in proteins to allow for more complex NMR studies may lower the yield of 
production even more. Our protocol produced, in one batch, sufficient amount of isotope-
labeled or fluorinated Aβ peptides to carry out NMR experiments. The strutural analysis and 
fibrillization kinetic assays of the recombinant Ab1-40 and Ab1-42 recapitulated the amyloid 
behavior previously described in the literature (91, 94, 232, 237, 244, 245). 
 
 
Figure 9: Representation of the tight control of NT* on the aggregation of amyloidogenic proteins. The 
polypeptide is largely unstructured and aggregation is inhibited in fusion with NT*. The cleavage of the 
fusion protein triggers the aggregation and enables controlled fibrillization studies. 
 
The low absorbance of FlSp NT* is an advantage, as compared to the use of MaSp NT* which 
contains a Trp, for detection of target proteins with a low absorbance at 280 nm. We 
hypothesized that the greater number of charges in FlSp NT* helps it to surpass the solubility 
enhancing aptitude of MaSp NT*. This is supported by studies highlighting that supercharging 
proteins increases their solubility (246, 247). In particular, FlSp NT* might be more suitable 
than MaSp NT* to prevent the aggregation of amyloid proteins because FlSp is the silk type 
predicted to be the one structurally closest to amyloid with segments predicted to form b-
hairpins (248). 
The studies in Paper IV and V present a facile, fast and cheap method to recombinantly produce 
amyloid proteins using NT* as a solubility enhancer. Both MaSp NT* and FlSp NT* enable 
the production of high yields of amyloid proteins, both in rich and minimal media. The behavior 
of amyloidogenic proteins produced with our protocol is essentially identical to the same 
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proteins produced by other means. With NT*, we provide a tool which can help to gain further 
knowledge on the molecular mechanism underlying amyloid formation (Figure 9) NT* may 
also facilitate the investigation of amyloid formation of other proteins, which could aid 
identification of potential anti-amyloid strategies with the goal to find treatments for amyloid-
related diseases. 
  
 41 
7 CONCLUSION AND PERSPECTIVES 
 
This thesis work sheds light on how spiders use the NT domain to manage their silk and we 
demonstrate how this knowledge can benefit protein production. Our studies on NT revealed 
that the dimerization of NT is a multistep procedure relying on electrostatic interactions 
followed by protonation of key residues. Using the knowledge provided by the molecular 
characterization of NT, we were able to design NT* and add it to the array of already available 
biotechnological tools which assist the production of aggregation- prone proteins.  
The investigations of the molecular mechanisms behind the pH-sensitive dimerization of MaSp 
NT and FlSp NT (Paper I and II) shed light on the residues involved in the process. We found 
that for both NTs, the association is initiated by the electrostatic interaction of Asp 40 with Lys 
65. In MaSp NT this interaction is stabilized by the sequential protonation of the pair Glu 79 
and Glu 119 first, and the protonation of Glu 84 at lower pH. The ability of FlSp to dimerize 
was confirmed but the protonation events did not involve the same set of residues. Similar 
results has been reported for other NTs (212, 213), and taken together, the results provide 
evidence that the dimerization mechanism is preserved between distantly related NT. Whether 
the difference in titratable residues is a mechanism to prevent cross-assembly of spidroins of 
distinct silks remains to be determined. The feasibility of the heterodimerization can, for 
example, be verified by monitoring with fluorescence correlation spectroscopy the binding of 
NTs from two different spidroins. A possible heterodimerization would open the possibility to 
mix two or more recombinant silk types and make composite artificial spider silk with 
improved properties.  
Studies of the NT domains are limited to a small amount of silk types and spider species and 
need to be broaden to have a complete picture of the implication of the evolution of NT on its 
function. For instance, several TuSp NTs are globally less charged than other NTs and they do 
not have some of the charged residues identified to be important for the dimerization. Future 
studies characterizing TuSp NT are needed to understand how this impacts NT dimerization 
and, de facto, its function. 
We harnessed the dimerization mechanism of NT to design the constitutive monomer NT* and 
used it for biotechnological applications in Papers III, IV and V. NT* displays suitable 
properties for a solubility tag, namely high thermal stability and high solubility. In a 
comparative study in Paper III, we showed that NT* gives higher yield than commonly used 
tags for the production of aggregation-prone proteins and peptides that are biomedically 
relevant. NT* was particularly potent for the soluble expression of transmembrane peptides 
that were efficiently purified via a non-chromatographic method using alternate steps of salt 
precipitation and centrifugation. In Paper IV and V, we highlighted that NT* is an excellent 
tool for comprehensive studies of amyloid proteins and can help to clarify the underlying 
molecular mechanisms of amyloid fibril formation. For future studies, it would be interesting 
to include NT* in a high throughput screening for solubility tags in order to evaluate its 
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performance with a larger set of proteins and get more insights on its mechanism of action. In 
general, it would be beneficial for the scientific community to constantly report yields of 
purified proteins in studies involving recombinant proteins. This would help scientists to 
compare and evaluate the available methods for protein productions, and choose the most 
appropriate ones for their protein of interest.  
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